ADR-002K for Patients With Ischemic Cardiomyopathy Who Undergo Coronary Artery Bypass Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-27

Study Completion Date

2021-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ischemic cardiomyopathy undergoing coronary artery bypass surgery

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by a K-ATP

NCT00212030

Acute Myocardial Infarction

COMPLETED NA

A Study of RTP-026 to Assess Safety, Tolerability and Efficacy in Patients With ST-Elevation Myocardial Infarction (STEMI)

NCT06465303

ST Elevation Myocardial Infarction

RECRUITING PHASE2

Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction

NCT02435797

Coronary Heart Disease

UNKNOWN PHASE4

Clinical Study of Cardiomyopeptidin on Postoperative Ischemia-reperfusion Injury in Patients With Primary PCI

NCT03958422

Survival Myocardial Area After Acute Myocardial Death Left Ventricular Ejection Fraction

UNKNOWN PHASE4

Evaluation in STEMI Patients Using FDY-5301

NCT04837001

Acute Myocardial Infarction STEMI Percutaneous Coronary Revascularization

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

D017202

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group of subjects undergoing cell transplantation

Group Type EXPERIMENTAL

ADR-002K administration

Intervention Type BIOLOGICAL

ADR-002K administration

Group of subjects undergoing sham operation

Group Type SHAM_COMPARATOR

ADR-002K administration

Intervention Type BIOLOGICAL

ADR-002K administration

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ADR-002K administration

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients who are clinically diagnosed with ischemic cardiomyopathy and receive CABG
2. Patients with a left ventricular ejection fraction of 40% or less by cardiac ultrasonography within 4 weeks before obtaining consent
3. Others

Exclusion Criteria

1. Patients who have a combination of cardiovascular disease such as severe organic valvular disease or aortic aneurysm determined by investigator or co-investigator to affect clinical trial procedure
2. Patients whose participation in a clinical trial is considered inappropriate at the discretion of the investigator or co-investigator
3. Others

Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No